Chief Medical Officer Consultant
Chief Medical Officer Consultant
Company: Clinical-Stage Oncology Biotechnology Company
Location: San Francisco, CA
Engagement: Contract Consulting Role
The Opportunity
Brio Resource Group is partnering with a clinical-stage oncology biotechnology company to identify an experienced Chief Medical Officer Consultant.
This executive consulting engagement will provide strategic medical leadership across clinical development, regulatory strategy, and organizational planning. The ideal candidate combines deep oncology expertise with a proven record of advancing novel therapeutics through clinical development and key regulatory milestones in emerging biotechnology environments.
Key Responsibilities
- Provide executive medical and clinical-development leadership across the company’s oncology portfolio.
- Shape clinical strategy, development plans, study designs, endpoints, and evidence-generation priorities.
- Oversee the design and execution of early- and late-stage oncology clinical trials.
- Partner with Clinical Operations, Regulatory Affairs, Biostatistics, Translational Medicine, Pharmacovigilance, and CMC.
- Lead medical input into regulatory submissions and interactions with the FDA and other global health authorities.
- Engage investigators, key opinion leaders, scientific advisors, and clinical-development partners.
- Evaluate clinical data, emerging safety signals, program risks, and development opportunities.
- Present clinical strategy and program updates to executive leadership, the Board of Directors, investors, and external partners.
- Support business-development activities, including scientific diligence, licensing opportunities, and strategic partnerships.
- Mentor clinical and medical team members while helping strengthen the organization’s development capabilities.
Qualifications
- MD or equivalent medical degree with board certification in oncology, hematology, or another relevant specialty.
- Substantial biotechnology or pharmaceutical leadership experience in oncology drug development.
- Previous Chief Medical Officer, Head of Clinical Development, or senior medical leadership experience.
- Demonstrated success advancing oncology programs through important clinical and regulatory milestones.
- Experience designing and overseeing global oncology trials across early- and/or late-stage development.
- Strong knowledge of FDA requirements, regulatory strategy, clinical safety, and benefit-risk assessment.
- Established relationships with oncology investigators, key opinion leaders, and scientific experts.
- Experience working effectively with executive teams, boards, investors, and external development partners.
- Ability to operate strategically and hands-on within a lean, fast-moving clinical-stage organization.
Why Consider This Opportunity?
This engagement offers meaningful executive leadership at a pivotal stage of development, the chance to shape the clinical and regulatory direction of an innovative oncology portfolio, and close collaboration with an accomplished leadership team advancing potential new therapies for patients with cancer.
